Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:
Appears in 2 contracts
Samples: License and Collaboration Agreement (Regulus Therapeutics Inc.), License and Collaboration Agreement (Regulus Therapeutics Inc.)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Payment for Royalty-Bearing Product Milestone Event: ([...***...]): Milestone Event:):
Appears in 1 contract
Samples: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:
Appears in 1 contract
Samples: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Milestone Event: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:):
Appears in 1 contract
Samples: License and Collaboration Agreement (Isis Pharmaceuticals Inc)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Milestone Event: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:
Appears in 1 contract
Samples: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Milestone Event: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:):
Appears in 1 contract
Samples: License and Collaboration Agreement (Isis Pharmaceuticals Inc)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Milestone Event: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:
Appears in 1 contract
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Milestone Event: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:):
Appears in 1 contract
Samples: License and Collaboration Agreement (Regulus Therapeutics Inc.)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Payment for Royalty-Bearing Milestone Event: Product ([...***...]): Milestone Event:
Appears in 1 contract
Samples: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)
Milestone Payments. Subject to Section 5.6(f), the Opt-In Party will pay to Regulus the following payments upon the achievement of the events set forth below by a Royalty-Bearing Product for the relevant Development Project: Milestone Event: Payment for Royalty-Bearing Product ([...***...]): Milestone Event:
Appears in 1 contract